Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SBRT Combined With QL1706 in Second-Line Treatment of Hepatocellular Carcinoma
NCT07668570Phase 4Not yet recruiting
- Sponsor
- The Fourth Hospital of Hebei Medical University
- Start
- Jul 2026
- Primary completion
- Jul 2029
01
Overview
A Phase 4 trial of QL1706 in hepatocellular carcinoma (HCC), sponsored by The Fourth Hospital of Hebei Medical University. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
QL1706
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT07668570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07668570.